Skip to main content

Market Overview

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB)

1.58 -0.03 (-1.86%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/17/20HC Wainwright & Co.MaintainsBuy8.0
5/22/20HC Wainwright & Co.MaintainsBuy6.0
3/02/20H.C. WainwrightReiteratesBuy4.0
11/22/19H.C. WainwrightInitiates Coverage OnBuy3.0
7/11/19Maxim GroupInitiates Coverage OnBuy
8/07/14JMP SecuritiesMaintainsMarket Outperform5.0
11/13/13Aegis CapitalMaintainsHold2.0
4/09/13Janney CapitalInitiates Coverage OnBuy5.0
3/05/13PiperJaffrayInitiates Coverage OnUnderweight1.5
1/22/13Burrill & CompanyInitiates Coverage OnOutperform5.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter